^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    LYL797

    i
    Other names: LYL797, LYL-797, LYL 797
    Company:
    Lyell Immunopharma
    Drug class:
    ROR1-targeted CAR-T immunotherapy
    Related drugs:
    Apply
    A Study to Investigate LYL797 in Adults With Solid Tumors (NCT05274451)
    Phase 1
    Lyell Immunopharma, Inc.
    Recruiting
    Last update posted :
    03/01/2024
    Initiation :
    03/29/2022
    Primary completion :
    03/01/2025
    Completion :
    09/01/2026
    ROR1
    |
    LYL797